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Hearing loss (HL) is often reported in patients with Turner Syndrome (TS). The aim of 
this study is to define the patterns of HL in these patients and all the possible factors 
that can promote the onset of sensorineural hearing loss (SNHL) in adult TS women. 
Three cohorts study of 31 TS women, 15 patients with congenital hypogonadism 
(OCH) and 41 healthy controls were identified. A detailed medical history was taken 
with special attention given to karyotype, age at diagnosis, previous history of 
oestrogen use and otorhinolaryngological history. Pshysical examination and hearing 
evaluation with pure-tone audiometry and brain auditory evoked potentials (BAEP) 
were performed. 
We found that the incidence of HL was higher in TS women compared to other groups, 
mainly in frequencies equal or higher than 1000Hz. According to previous studies, 
SNHL was the mostfrequent type of hearing impairment among middle-aged TS 
women, suggesting a premature presbyacusia. TS patients with previous history of 
recurrent otitis also had an increased incidence of HL. No statistically significant 
differences were found between groups in BAEPs latencies and amplitudes. Some 
autors suggested that HL related genes may be located on the short arm of the X-
chromosome and we found that monosomies and isochromosomes presented a 
significant higher hearing threshold. The lack of endogenous oestrogens has been also 
proposed as a contributing cause for SNHL, we didn’t find statistically significant 
differences between TS women with normal and low oestrogen levels or between TS 







Turner syndrome (TS) is one of the most common human genetic disorders, occurring 
in approximately 1:2500 live females. Affected subjects have a range of problems 
associated with loss of an entire sex chromosome or a portion of it, specially, the distal 
part of the short arm. Gonadaldygenesis and short stature are the main characteristics 
of TS. However, other medical conditions such as cardiovascular abnormalities, 
hypothyroidism, osteoporosis and non-verbal learning disabilities are linked with this 
syndrome8,11,13. 
 
Hearing loss (HL) and middle ear disease are often reported in some patients with 
TS19,21,23,27. Young and middle-aged women with TS have a progressive type of hearing 
impairment, deteriorating rapidly in adult age. The conductive hearing loss (CHL) 
seems to be a consequence of several episodes of otitis media during infancy. The 
cause for the infection is related to the deformity in the pinna, more pronounced in 
patients with a total delection of the short arm of the X chromosome, as monosomy 
45X0 or isochromosome33. The literature characterizes the sensorineural hearing 
decline as two patterns: a mid-frequency dip, and a high frequency loss resembling 
age-related hearing impairment (presbyacusia)21,22,27,33. Therefore, the conductive loss 
may have a genetic origin, while the pathophysiology of sensorineural lesions is not yet 
fully understood. Some studies indicate that cochlear dysfunction is the cause of the 
sensorineural impairment, and it is possibly influenced by oestrogen deficiency 22,29.  
 
The relation between otologic disease and karyotype23,33, the impact of oestrogen 
deficiency on hearing10,17,20, the physiopathology of the sensorineural hearing loss 
(SNHL) or the identification of otolaryngologic markers for the early diagnosis of TS24, 
are questions pending resolution.  
 
The aim of the present study was to define better the patterns and causes of HL 
associated to TS, using subjective and objective diagnosis tools. Remarkably, to the 
best of our knowledge, no previous studies exist where TS women were compared with 
OCH in terms of hearing loss. On the above evidence, the current investigation was 
undertaken to deal this subject using TS patients, but also two appropriate comparator 






Study design and population 
An analytical study of three independent cohorts was designed. The first cohort 
corresponds to 31 TS patients recruited by the Gynaecological Endocrinology Unit of 
the Hospital Clinic of Barcelona. The diagnosis of TS was confirmed by blood karyotype 
showing a total or partial absence or alteration of X chromosome in at least, more than 
10% of cells. Inclusion criteria were TS subjects between 20 and 50 years of age 
receiving hormone replacement treatment. 
 
A total of 15 women with congenital hypogonadism and wild-type karyotype, receiving 
hormone replacement treatment, composed a second cohort. This cohort includes 
subjects with pure gonadal dysgenesis (hypergonadotrophic hypogonadism), and with 
idiopathic hypogonadotrophic hypogonadims. Kallman’s syndrome patients were 
excluded because of its possible association with sensorineural hearing loss 5,15. The 
aim to include this group was to define the role of congenital hypooestrogenism in 
hearing decline associated with TS.  
 
The third cohort included 41 non-exposed age-matched cases, as controls, were all 
treated with oestrogen and progestagens with the aim of contraception. The 
gynaecological department recruited them. None of them took any other drug that 
could interfere with the study results. Animal 16,29,31 and human 28,30studies indicate 
that oestrogens could have and impact on hearing. Moreover, cycling hearing 
alterations have been described in women with normal menstrual cycle. High pure-tone 
thresholds have been found during the menstrual phase, when the levels of circulating 
estrogens are at their lowest22,32. This was not seen in women using oral 
contraceptives. Therefore, a control group receiving exogenous hormones was selected 
for the present study, in order to mimic as much as possible the hormone status of the 
main study group.  
 
Exclusion criteria were the presence of acute or chronic pathologies non-related with 
the syndrome being studied which could interfere with the analysis, such as head 
injury, Meniere’s disease or cerebellopontine angle or intracanalicular tumors20. The 
study protocol was reviewed and approved by the Ethics Committee of the 
HospitalClinic of Barcelona, and it was performed in accordance with the Helsinki II 
Declaration 
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and the ICH Guidelines for Good Clinical Practice. All patients were informed about the 
study and the interventions that would be performed and signed informed consent was 
obtained from all of them at the time of inclusion. 
 
Interventions 
Clinical history: blood karyotype, age at diagnosis of hypogonadism and previous 
history of oestrogen use were collected. Patients with spontaneous menarche before 
16 years of age (and consequently, spontaneous development of secondary sexual 
characteristics) or age at diagnosis before 16 years old (and consequently, with the 
beginning of oestrogen replacement therapy before 16 years) were considered as 
patients with normal puberty. Additionally, data of otorhinolaryngological (ENT) history 
was recorded, as history of recurrent episodes of otitis media, tubes insertion, 
tonsillectomy or adenoidectomy, or family history of hypoacusia.  
 
Physical examination: measurement of height and weight. Microotoscopy in order to 
evaluate the external auditory canal and the eardrum was carried out by two 
experienced ENT specialists without knowing which of the three study groups the 
patients belonged.  
 
Standard pure tone audiometrywas performed to all participants, according to 
standards audiometric methods (ISO 389), using a clinical audiometer at octave 
intervals from 250 to 8000 Hz. All hearing test were carried out by the same trained 
audiologist in a soundproof booth, with background levels well-below the accepted 
standards. As always, there can be a 5 dB machine error rate associated with 
audiogram measurement. 
Audiometry results were categorised as normal if the air conduction (AC) thresholds 
were equal to or lower than 20 dB across the frequency range of 250 to 8000Hz.  
However, if there was an apparent loss of only 5 dB HL at only one frequency, the ear 
audiometry was also considered normal for the purposes of this analysis. Hearing loss 
(HL) was defined as AC thresholds higher than 20 dB at one or more frequencies in the 
range of 250 to 8000 Hz. In these cases, bone conduction was performed in order to 
classify the type hearing loss. Conductive hearing loss (CHL) was defined as AC 
thresholds higher than 20 dB with an air-bone gap (ABG) of at least 10 dB at one or 
more frequencies, being bone conduction (BC) thresholds less than 20 dB at any 
frequency. Patients with a pure sensorineural hearing loss (SNHL) resented the AC 
thresholds worse than 20 dB HL at one or more frequencies in the range of 250 to 
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8000 Hz, with ABG lower than 10 dB. Finally, subjects with a mixed (MHL) conductive 
and sensorineural hearing loss were defined as BC thresholds worse than 20 dB HL at 
one or more frequencies with an ABG of at least 10 dB at one or more frequencies31.  
Degree of hearing loss was based on a four frequency (500, 1000, 2000 and 4000 Hz) 
pure-tone air conduction average, following the schemes adapted from the European 
Working Group on the Genetics of Hearing Impairment23. Mild hearing loss includes 
pure-tone air conduction average from 20 dB to <40 dB; moderate, from 40dB to 
<70dB; severe, from 70 dB to< 95dB; and profound, equal or higher than 95 dB20. 
HL was also assessed using the American Academy of Otolaryngology 1979 (AAO) 
equation. This equation is broadly used in occupational hearing decline and is obtained 
as follows; The average of 500, 1000, 2000 and 3000 Hz threshold was calculated per 
ear. From the average 25dB were subtracted, and the result was multiplied by 1.5. 
This result gave the percentage of HL of the ear. To calculate the binaural score the 
following formula is applied: 
% binaural score = (5 x (best ear score) + 1 x (worst ear score))/6 
 
Brain Auditory evoked potentials (BAEP) were performed to TS patients and OCH 
group. BAEP results were compared to the reference population data of our hospital. 
BAEP were registered using a two-canal recording device of a Medelec Synergy EP 
machine. The lower filter was 100Hz, and the upper one 3000Hz. The stimulus 
consisted of alternating clicks, presented monaurally with a rhythm of 20 times per 
second. The medium response of 1500 stimuli was registered for 10 ms. First of all, the 
latency of V wave was recorded at different intensities of the stimulus, between 30dB 
and a maximum of 110dB in order to find out the threshold of hearing and to establish 
with the best accuracy the type of deafness. Auditory brain response (ABR) was done 
afterwards. The intensity of the stimulus applied was 60dB higher than the threshold of 
hearing. Morphology, latencies of peaks I, III and V, as well as interpeaks I-III, III-V 
and I-V were recorded. Two replications, each to 1500 stimuli, were obtained for each 
stimulus intensity for each ear tested. Each recording was individually analyzed by the 
testing audiologist and by two neurologist of the hospital.  
BAEP have been extensively validated as an objective diagnostic tool for sensorineural 
hearing loss, monitoring the pathway from the cochlea to the level of brainstem. Wave 
I is the result of the volley generated by the click stimulus in the distal part of the eight 
nerve. Consequently, changes in the amplitude or latency of this wave suggest damage 
of the coclea or the distal part of the eight nerve. Nevertheless, abnormal absolute 
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latencies of waves II-V or interlatencies I-III, III-V are strongly indicative of 
retrococlear hearing loss.   In conductive deafness the hearing threshold is high, wave 
I to V are usually shifted to the right but the I-V interval is normal and the latency-
intensity curve for wave V runs above the normal curve and is parallel to it. However, 
in sensorineural deafness the threshold of hearing may be high, the latency-intensity 
curve is of recruiting type so at high intensity, the curve is normal, but at lower 
intensity the wave V latency is prolonged disproportionately. Latencies in cases with 
sensorineural hearing loss are within the ranges seen in normal hearing individuals6.  
 
Statistical analysis: 
Statistical analysis was performed using the the software SPSS v19 (SPSS 19.0, SPSS 
Inc. Headquarters, 223 South Wacker Drive, Chicago, IL 60606, USA). Qualitative 
variables were described using frequency tables, whereas quantitative variables were 
described by their average and standard deviation.  A T-student test was performed to 
compare averages between groups in those variables following normality, according to 
Kolmogorov-Smirnov. Conversely, when the variables did not fit into normality, a Mann 
Whitney U-test was carried out. A binomial test was used to compare frequency 
variables. All statistical hypotheses to be testes were carried out considering an alpha 




















Clinical and anthropometrical characteristics of the subjects are shown in Table 1. As 
expected, controls and OCH were taller than TS patients. More than one third of TS 
patients underwent tonsillectomy and adenoidectomy, and only a quarter did not suffer 
from recurrent otitis media in childhood. However, a low percentage of TS women 
have deformed external acoustic meatus or affected eardrum.  
 
Analysing pure tone audiometry results, 27 (87%) of TS patients suffer some degree of 
HL, compared with 3 OCH (20%) and 11 controls (27%). When outcomes of the AAO 
equation were compared between groups, TS women bear a significant HL in respect 
to OCH group and control group (Figure 1). Statistically significant differences were 
found between TS and controls considering the right ear (p=0.001), left ear (p<0.02) 
and binaural loss (p<0.001). Equally, differences were found between TS and OCH in 
right ear (p=0.015), left ear (p=0.002) and both ears (0.009). Figure 2 shows air 
conduction (AC) hearing thresholds across the frequency range from 250 to 8000 Hz of 
the three study groups. Again, statistically significant differences were found in 
frequencies equal or higher than 1000 Hz between TS and OCH (p<0.05) and TS and 
controls (p<0.01), both in the right ear or left. Comparing the results of both ears, no 
differences were found between right and left ear. 
Patients were divided considering the degree of HL (Figure 3). The majority of 
patients of the control group and OCH presented normal hearing function, with a low 
proportion of females with mild hypoacusia. Conversely, much more number of 
patients suffering moderate, severe or profound hypoacusia were found in TS group 
than in controls or OCH.  
Following the classification criteria described previously, SNHL was the most frequent 
type of defect found in TS group (11 patients in the right ear, and 13 in the left), 
followed by CHL (8 patients in the right ear, and 8 more in the left) and MHL (4 
affected right ears, and 4 left ears). The low percentage of affected controls was 
diagnosed by CHL (3 in the right ear, and 7 in the left ear), while OCH suffered SNHL 
(2 in the right ear, and 3 in the left ear) (Figure 4). 
 
The latency-intensity curve for wave V concluded that hearing threshold was improper 
in 33 ears (54.1%), which accounts for 19 TS patients (61%); in 14 TS patients 
bilaterally and in 5 cases one sided. According to pure tone audiometry results, just the 
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20% (6 ears affected) of OCH patients presented HL. Nevertheless, up to 8 TS patients 
with impaired audiometry results presented normal BAEP. 
Following the classification criteria described previously, mild hearing loss was detected 
in 18 ears (29.5%); moderated hearing loss in 12 ears (19.7%); severe hearing loss in 
2 ears (3.27%) and profound hearing loss in only one ear (1.63%). CHL was present in 
4 ears (6.55%), mixed hearing loss in 3 ears (4.9%) and SNHL in 26 (42.6%). Type of 
HL evaluated by BAEP was in accordance with audiometry, except in a group TS 
patients analysed as mild CHL in the audiometry, which was evaluated as normal in 
BAEP; probably due to its greater objectivity. 
Finally, the results of BAEP were analyzed. ABR-wave I was reliable indentified in 27 
cases, wave III in 29 and wave V in all cases (31 TS patients). Mean and standard 
deviation of latencies, amplitudes and interpeaks of waves I, III and V are shown in 
(Table 2). No statistically significant differences were found either between TS and 
OCH, or TS and values of reference population. 
 
Several sub-analysis between groups of TS patients were performed in order to explore 
possible associations of HL with karyotype, hormonal status, history of recurrent otitis 
media and age.  
First of all, TS patients were divided considering the presence of the short arm of X 
chromosome. Complete absence sub-group included patients with pure monosomy 
(45X0) or isochromosome (45X0/46i(X)). The rest of mosaicisms or structural 
anomalies formed the second sub-group. Statistically significant differences were found 
between groups in 8000 Hz, where monosomies and isochromosomes presented higher 
threshold than the others (p=0.01 in T-student test). 
The second sub-analysis divided TS patients considering the hormonal status during 
puberty. Patients with normal puberty (as defined in methods section) and TS women 
without normal oestrogen levels at the end of the puberty were compared. No 
statistically significant differences were found between groups.  
Two groups of TS females were performed considering age: patients from 20 to 35 
years, and women from 35 to 50. As expected, statistically significant differences were 
found between groups, with higher threshold in mid and high frequencies (2000, 4000 
and 8000 Hz) in the oldest group (p<0.05).  
The last sub-analysis was carried out dividing TS patients with a history of recurrent 
otitis media during childhood, and those without history. HL was statistically significant 




The main findings of the present study are: more than a half of TS females presented 
HL in pure-tone audiometry, confirmed by BAEP; SNHL is the most frequent type of 
hearing impairment among middle-aged women with TS; and age, karyotype and 
history of recurrent otitis media are likely to be factors that promote hearing loss 
among TS patients. 
 
In the present study, we observed HL in almost 90% of females with TS evaluated by 
audiometry. Nevertheless, improper hearing analyzed by BAEP was found in 
approximately one-half of TS patients, in concordance with previous reports17,23. These 
differences may be due to an upper normality threshold in BAEP (30dB vs 20dB in 
audiometry) and the higher objectivity of this neurological technique. However, direct 
comparisons with other works are difficult due to the disparities in how HL is defined 
and categorized. The majority of the studies are performed in children with TS17,26,27,33, 
with a high percentage of them showing CHL. The aetiology of this increased incidence 
of middle ear pathology in TS is thought to be due to early defects in lymphatic 
channels and aberrant anatomic shaping of structures derived from the first and 
second brachial arches, causing abnormally horizontal Eustachian tubes and palatal 
dysfunction18. Worse quality of epithelium is also reported in those patients17. All this 
factors predisposed to otitis media. Twelve TS females presented CHL (pure or mixed) 
in the present study, according to these data.  
 
Otherwise, older population has an increased incidence of SNHL27. Taking into account 
that our TS patients studied are from 20 to 50 years of age, comparison should be 
done with other studies performed in populations of similar ages. Hederstierna and 
coworkers20 studied 30 TS women aged 40-67, with mild to moderate HL, aimed at 
localizing the lesion causing the SNHL and assessing central auditory function. As 
already mentioned, ABR-latencies in the present study were within reference mean +/- 
2SD in all 31 TS cases. No ABR amplitudes and absolute and interpeaks latencies of 
our TS-cases were not significantly prolonged compared to the reference population, in 
accordance with Hedestierna study. Fifteen of the thirty-one TS cases had mild to 
moderate hearing loss and three of them showed an absence of wave I, suggesting 
cochlear dysfunction as the cause of this hearing loss impairment. The last case of 
unilaterally absence of wave I suffered from a severe hearing loss. Unlike Hedesternia’s 
results, shorter V latencies were not found in our study. There are contradictory 
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reports in literature, nevertheless. Other previous studies17,18 also showed prolonged 
absolute ABR latencies, but interpeak latencies were completely normal in all cases. 
 
The most frequent type of HL found in our sample was SNHL. The literature 
characterizes the SNHL in TS women as two patterns: a bilateral symmetrical mid-
frequency dip, maximal at 2 Hz. and a high-frequency down-sloping SNHL21. No cases 
of clear mid-frequency dip were found in TS females in the present study. This could 
be due to the fact that a majority of TS women develop a moderate to profound high-
frequency loss20, leaving only the low-frequencies spared. This audiometric pattern was 
the most frequently observed in our TS population.  
 
A cell cycle delay has been explained as a possible cause of SNHL in TS.  Whereas in 
healthy subjects the density of hair cells in the Organ of Corti is highest in the middle 
turn of the cochlea, a lack of sensory hair cells within the cochlea exists in TS patients.  
This defect has been hypothesized as the cause of the mid-frequency hearing loss, 
while the apoptosis attributable to age has been suggested as the responsible of the 
presbyacusia.  Therefore, both CHL and SNHL could be explained by developmental 
period alterations in TS women17. The severity of TS dysmorphology is related to 
karyotype8,14,24. There are suggestions that the hearing impairment related genes may 
be located on the short arm of the X-chromosome22. According to this hypothesis, a 
higher ocurrence of ear and hearing defects is expected in TS patients with monosomy 
or isochromosome compared to those with a mosaicism or structural anomaly33. The 
results of the sub-analysis perfomed in the present study between monosomy or 
isochromosome versus the rest of karyotypes are in accordance with this hypothesis: 
worse results in high frequencies were found. 
Additionally, the lack of endogenous oestrogens has been proposed as a contributing 
cause for SNHL. Oestrogens receptors have been found in the inner ear in rats and 
mice29, and also in human fetuses, adults and TS fetus30. Coleman and coworkers7 
proved improvement of BAEP latencies scores in ovariectomised rats after hormonal 
replacement therapy. A lack of appropriate hormonal treatment during childhood has 
been suggested as one cause of the extensive hearing problems found among older TS 
women22,26. Following this line, TS patients were divided again in two sub-groups: with 
normal hormonal status at 16 years of age, or lack of sexual development. No 
statistically significant differences in hearing status were found between groups in the 
present study. Furthermore, it is worth to note that no statistically significant 
differences were found between controls and OCH in any hearing test, while 
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differences were found between OCH and TS patients. TS is a suitable human model 
for the assessment of physiological processes in organs that have matured in a 
deficient oestrogen environment20, but also are indeed patients with congenital 
hypogonadisms having normal karyotype. No hearing decline was found among 
patients of this second group (OCH group), which additionally suffered an even more 
delay than TS in the oestrogen deficiency diagnosis due to the lack of dysmorphology 
(Table 1). This new group of study suggests a minor role of oestrogens in HL, although 
further studies are needed to solve such issue.  
 
Hearing decline in women, in general, fairly slow up until the age around 50 years, but 
accelerates after the menopause. TS patients suffer a rapidly progressive hearing 
decline with age. The rate of progression in young and middle-aged women with TS is 
on a level comparable to that seen in 70-89 year-old women in the general population, 
especially in high frequencies19. After dividing TS patients in two groups, considering 
age, higher threshold values were observed in the oldest group in mid and high 
frequencies, in agreement with previous studies19,21,23. This decline in hearing may 
reflect a premature loss of sensory function, residual cochlear sequelae of otitis media, 
or both21. It is important to note that the hearing impairment becomes more socially 
handicapping when a high-frequency loss joins the the mid-frequency dip developed 
previously19. 
Last sub-analysis was carried out sorting TS patients with and without history of otitis 
media during childhood. Interestingly, statistically significant differences were found 
between groups, with worse results in TS with history of otitis, in the lowest and the 
highest frequencies. Mid-frequency dip pattern seems to be independent of otitis 
media and it is typically present in TS adolescents17,32. No differences were found 
between groups at mid-frequencies, probably due to the alterations of these 
frequencies in a high percentage of TS adolescents, with and without history of middle 
ear infection.  
 
Some limitations exist in the present study. The low sample size, especially in the case 
of TS sub-groups analyses, should make these results interpreted with caution. 
However, some selection biases have been avoided with the recruitment through a 
gynaecological unit instead of specialty otorhinological referral clinics, giving a more 
realistically prevalence of hearing disorders in TS women. In addition, the comparison 
between TS and OCH adds absolutely new type of data for the study of the role of 
oestrogens in hearing function. 
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CONCLUSION 
A progressive hearing loss is associated with TS, being SNHL the most frequent pattern 
of hearing decline. The etiology of HL is no doubt heterogeneous, with a strong genetic 
influence, but also recurrent history of otitis media. However, the role of the lack of 
endogenous oestrogens becomes less important, although further studies are needed 
to define it. Regular audiometric test in adults patients with TS are required due to 
their much earlier development of presbyacusia with low percentages of complains 
about subjective hearing deterioration17. However, the single medical intervention to 





































Table 1. Clinical and antrhopometrical characteristics of the three study groups.  
Comparisons between groups were performed using student T-test for continuous 
variables, while binomial test was used to compare percentages. BMI = Body Mass 
Index. HRT = Hormone Replacement Treatment. 
 
 
 Controls  
(n = 41) 
Other congenital 
hypogonadisms 
(n = 15) 
Turner’s 
syndrome  
(n = 31) 
Age, years (Mean ± SD)  34.6 ± 7.6 32.7 ± 8.5 36.6 ± 8.1 
Height, cm (Mean ± SD) 163.4 ± 
5.2 
162.1 ± 8.7 148.8 ± 7.5** 
BMI,  kg/m2 (Mean ± SD)  22.7 ± 4.0 22.3 ± 13.8 25.1 ± 3.8* 
Age at diagnosis (Mean ± 
SD) years 
- 16.7 ± 3.0 10.5 ± 10.2† 
Age at beginning of HRT, 
years (Mean ± SD) 
- 17.8 ± 3.7 17.8 ± 5.3 
Spontaneous menarque. N 
(%) 
41 (100) 9(60)** 10 (32)* 
Hearing history 
Familial hipoacusia history.  
N (%) 
6 (15) 3 (20) 5 (16) 
Adenoidectomy. N (%) 4 (10) 1 (6) 10 (32)* 
Tonsilectomy. N (%) 4 (10) 1 (6) 11 (35)* 
Recurrent otitis media. N 
(%) 
   
 No  13 (87) 13 (87) 8 (26)* 
 Bilateral.   2 (13) 2 (13) 12 (39) 
 Only right.  0 (0) 0 (0) 5 (16) 
 Only left.  0 (0) 0 (0) 6 (19) 
Deformed external 
acoustic meatus. N (%) 
   
 No 15 (100) 15 (100) 27 (87) 
 Bilateral.  0 (0) 0 (0) 3 (10) 
 Only right. 0 (0) 0 (0) 0 (0) 
 Only left.  0 (0) 0 (0) 1 (3) 
Affected eardrum . N (%)    
 No 15 (100) 15 (100) 24 (77) 
 Bilateral  0 (0) 0 (0) 3 (10) 
 Only right.  0 (0) 0 (0) 1 (3) 
 Only left.  0 (0) 0 (0) 3 (10) 
 
*p <0.05 comparing with control group. 
**p <0.01 comparing with control group. 





Table 2 – Results of Brain Auditory Evoked Potentials (BAEP) of Turner’s syndrome 
patients and other congenital hypogonadisms. Values of the reference Spanish 
population are shown. No statistically significant differences were found between 














(n = 31) 
Hearing 
threshold (dB).  
<20dB 23.37 ± 8.48 36.00 ± 18.17 
Latency Wave I 
(ms) 
1.7 ± 0.15 1.62 ± 0.31 1.80 ± 0.23 
Latency Wave III 
(ms) 
3.9 ± 0.19 3.67 ± 0.74 3.86 ± 0.18 
Latency Wave V 
(ms) 
5.7 ± 0.25 5.43 ± 1.10 5.75 ± 0.30 
Amplitude Wave 
I (!V) 
0.28 ± 0.14 0.35 ± 0.16 0.19 ± 0.10 
Amplitude Wave 
III (!V) 
0.23 ± 0.12 0.31 ± 0.14 0.22 ± 0.10 
Amplitude Wave 
V (!V) 
0.43 ± 0.16 1.44 ± 5.01 0.35 ± 0.14 
Interpeak I-III 
(ms) 
2.1 ± 0.15 1.98 ± 0.57 2.05 ± 0.18 
Interpeak III-V 
(ms) 
1.9 ± 0.18 1.68 ± 0.51 1.85 ± 0.17 
Interpeak I-V 
(ms) 


















* TS bear a significant hearing loss compared to controls (p = 0.001) and compared to 
OCH (p=0.015) in a Mann-Whitney test 
+ TS bear a significant hearing loss compared to controls (p < 0.001) and compared to 
OCH (p=0.02) in a Mann-Whitney test 
† TS bear a significant hearin loss compared to controls (p <0.001) and compared to 













Figure 2. Pure-tone audiometry results of the three study groups. Air conduction 
hearing thresholds across the frequency range from 250 to 8000 Hz. Average and 
confidence interval 95% are depicted. (**) indicates p<0.01 between TS and control 













Figure 3. Number of patients of the three study groups and degrees of hypoacusia.  










Figure 4. Number of patients of the three study groups and types of hypoacusia. CHL: 
conductive hearing loss; SNHL: sensorineural hearing loss; MHL: mixed hearing loss; 
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